ethinyl estradiol has been researched along with Obesity in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (22.54) | 18.7374 |
1990's | 2 (2.82) | 18.2507 |
2000's | 18 (25.35) | 29.6817 |
2010's | 32 (45.07) | 24.3611 |
2020's | 3 (4.23) | 2.80 |
Authors | Studies |
---|---|
Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H | 1 |
Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G | 1 |
Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
Adeyanju, OA; Olatunji, LA; Soetan, OA; Soladoye, AO | 1 |
Adler, TE; Stachenfeld, NS; Takamata, A; Usselman, CW | 1 |
Edelman, AB; Jusko, WJ; Luo, D; Natavio, M; Stanczyk, FZ; Westhoff, CL | 1 |
Bender, JR; Leone, CA; Stachenfeld, NS; Steele, FE; Taylor, HS; Usselman, CW; Yarovinsky, TO | 1 |
Conway, GS; Lee, MC | 1 |
Mayeda, ER; Torgal, AH; Westhoff, CL | 1 |
Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR; Portman, D; Rubin, A; Westhoff, CL | 1 |
Bangerter, K; Merz, M; Reinecke, I; Westhoff, CL | 1 |
Cherala, G; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
Archer, DF; Foegh, M; Kaunitz, AM; Mishell, DR | 1 |
Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
Archer, DF; Nakajima, ST; Pappadakis, J | 1 |
Ellakwa, H; Gamal, A; Rezk, M; Sayyed, T; Zahran, A | 1 |
Jusko, WJ | 1 |
Cao, Y; Jiang, Y; Wu, J; Zhu, Y | 1 |
del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
Cameron, JL; Carlson, NE; Cherala, G; Edelman, AB; Jensen, JT; Munar, MY; Stanczyk, FZ; Stouffer, RL | 1 |
Cleuren, AC; Hoylaerts, MF; Lijnen, HR; van Hoef, B; van Vlijmen, BJ | 1 |
Chen, HF; Chen, MJ; Chen, SU; Ho, HN; Kuo, JJ; Yang, WS; Yang, YS | 1 |
Edelman, A; Patel, S; Stanczyk, FZ; Steiner, AZ | 1 |
Weisberg, E | 1 |
Mayeda, ER; Pike, MC; Stanczyk, FZ; Torgal, AH; Westhoff, CL | 1 |
Benn, EKT; Lerner, JP; Mayeda, ER; Paik, M; Stanczyk, FZ; Torgal, AH; Westhoff, CL | 1 |
Cherala, G; Edelman, AB; Stanczyk, FZ | 1 |
Bulechowsky, M; Cameron, J; Edelman, A; Jensen, JT | 1 |
Cheang, KI; Essah, PA; Nestler, JE; Sharma, S; Wickham, EP | 1 |
Adawadkar, SS; Arrowood, JA; Cheang, KI; Essah, PA; Nestler, JE; Stovall, DW | 1 |
Beasley, A; Estes, C; Guerrero, J; Westhoff, C | 1 |
Mayeda, ER; Pike, MC; Shimoni, N; Stanczyk, FZ; Torgal, AT; Westhoff, CL | 1 |
Cherala, G; Edelman, A; Elman, MR; Koop, D; Munar, M | 1 |
Cremers, S; Dragoman, M; Mayeda, ER; Petrie, K; Thomas, T; Torgal, AH; Westhoff, CL | 1 |
Archer, DF; Foegh, M; Mishell, DR; Rubin, A; Stanczyk, FZ | 1 |
Cherala, G; Dubois, B; Edelman, AB; Jensen, JT; McInnis, M; Munar, MY; Stanczyk, FZ | 1 |
Cremers, S; Dragoman, M; Petrie, K; Thomas, T; Torgal, A; Westhoff, CL | 1 |
Wemeau-jacquemont, C | 1 |
Bussen, SS; Dietl, J; Rieger, L; Steck, T; Sütterlin, MW | 1 |
Bialer, M; Doose, DR; Jacobs, D; Padmanabhan, M; Schwabe, S; Wang, SS | 1 |
Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 1 |
DEMOWBRAY, RR | 1 |
Hedberg, P; Morin-Papunen, L; Puukka, M; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
Harma, M; Kilic, F; Nazligul, Y; Sabuncu, T | 1 |
De Zegher, F; Ibáñez, L | 1 |
Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS | 1 |
Déchêne, F; Dodin, S; Forest, JC; Lemay, A; Turcot, L | 1 |
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
Atlas, M; Gordon, L; Januchowski, R; Thakur, N | 1 |
Demirci, F; Gul, OB; Ozdemir, I; Somunkiran, A; Yucel, O | 1 |
Grewal, S; Iroh Tam, PY; Richardson, M | 1 |
Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG | 1 |
Evans, E; Massoudi, M; Miller, DS | 1 |
Gallasch, E; Klöpping, K; Neumeyer, H; Seidel, D; Wieland, H | 1 |
Rubio Lotvin, B | 1 |
Arner, P; Bergqvist, A; Carlström, K; Ek, I; Reynisdottir, S; Wahrenberg, H | 1 |
Koivunen, RM; Martikainen, HK; Morin-Papunen, LC; Ruokonen, A; Tapanainen, JS; Vauhkonen, I | 1 |
Lauritzen, C | 1 |
Brion, JP; Copinschi, G; De Laet, MH; Delvoye, P; Golstein, J; L'Hermite, M; Leclercq, R; Robyn, C; Van Cauter, E; Vanhaelst, L; Vekemans, M; Virasoro, E | 1 |
Hommel, G; Muck, BR | 1 |
Friedlander, DH; Snell, AP | 1 |
Mauvais-Jarvis, P; Plouin, PF | 1 |
Dunn, FG; Fife, R; Jones, JV | 1 |
Fotherby, K | 1 |
Stokes, T; Wynn, V | 1 |
Hancock, KW; Levell, MJ | 1 |
Diddle, AW; Semmer, JR | 1 |
Brohult, J; Westgren, A | 1 |
Boshell, BR; Fox, OJ; McAdams, GL; Roddam, RF | 1 |
6 review(s) available for ethinyl estradiol and Obesity
Article | Year |
---|---|
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
Altered pharmacokinetics of combined oral contraceptives in obesity - multistudy assessment.
Topics: Clinical Studies as Topic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Humans; Levonorgestrel; Obesity | 2019 |
Liver dysfunction in Turner syndrome and its relationship to exogenous oestrogen.
Topics: Bile Duct Diseases; Biopsy; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Liver; Liver Diseases; Obesity; Turner Syndrome | 2013 |
Clarification of contraceptive drug pharmacokinetics in obesity.
Topics: Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity | 2017 |
Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review.
Topics: Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Intestinal Absorption; Obesity; Progestins; Skin Absorption; Steroids | 2010 |
Oral contraceptives, lipids and cardiovascular disease.
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking | 1985 |
34 trial(s) available for ethinyl estradiol and Obesity
Article | Year |
---|---|
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Isoflavones; Metformin; Obesity; Polycystic Ovary Syndrome; Primary Ovarian Insufficiency; Sex Hormone-Binding Globulin; Superoxide Dismutase; Tablets; Testosterone; Treatment Outcome; Young Adult | 2021 |
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.
Topics: Adult; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Endothelin-1; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Microvessels; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Receptor, Endothelin B; Skin; Vascular Endothelial Growth Factor A; Vasodilation; Young Adult | 2019 |
Weight and body composition changes during oral contraceptive use in obese and normal weight women.
Topics: Adult; Body Composition; Body Mass Index; Contraceptives, Oral; Dose-Response Relationship, Drug; Electric Impedance; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Obesity; Outcome Assessment, Health Care; Prospective Studies; Time Factors; Weight Gain; Weight Loss; Young Adult | 2014 |
Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethnicity; Female; Humans; Levonorgestrel; Obesity; Patient Compliance; Pregnancy; Transdermal Patch; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Female; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicular Phase; Follow-Up Studies; Humans; Lost to Follow-Up; Norpregnenes; Obesity; Oogenesis; Ovarian Follicle; Overweight; Ovulation Inhibition; Progesterone; Sex Hormone-Binding Globulin; Transdermal Patch; Ultrasonography; Young Adult | 2014 |
Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Prospective Studies; Young Adult | 2014 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Obesity; Patient Outcome Assessment; Transdermal Patch; Young Adult | 2015 |
Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Obesity; Pregnancy; Pregnancy, Unplanned; Young Adult | 2016 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Fasting; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Insulin; Luteinizing Hormone; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone; Waist-Hip Ratio | 2008 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Menstrual Cycle; Obesity; Organ Size; Ovarian Follicle; Ovulation Inhibition; Progesterone; Radioimmunoassay; Ultrasonography; Young Adult | 2010 |
Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Ovary; Prospective Studies; Young Adult | 2010 |
Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women.
Topics: Academic Medical Centers; Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipoproteins, LDL; Norgestrel; Obesity; Prospective Studies; Thinness; Time Factors; Virginia; Young Adult | 2011 |
Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Norgestrel; Obesity; Overweight; Placebo Effect; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Vasodilation; Virginia | 2011 |
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Levonorgestrel; Lipid Metabolism; Medication Adherence; Obesity; Patient Dropouts; Triglycerides; Young Adult | 2012 |
Predictors of noncompliance in an oral contraceptive clinical trial.
Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Educational Status; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Levonorgestrel; Medication Adherence; Obesity; Ovarian Follicle; Ovulation Inhibition; Patient Dropouts; Poverty; Single-Blind Method; United States; Young Adult | 2012 |
Effect of the ethinylestradiol/levonorgestrel combined oral contraceptive on the activity of cytochrome P4503A in obese women.
Topics: Adolescent; Adult; Chromatography, Liquid; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Midazolam; Obesity; Prospective Studies; Tandem Mass Spectrometry; Young Adult | 2012 |
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Endometrium; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation; Obesity; Ovarian Follicle; Prospective Studies; Young Adult | 2012 |
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Middle Aged; Obesity; Ovary; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 2013 |
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Obesity; Ovarian Follicle; Prospective Studies; Vagina; Young Adult | 2013 |
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
Topics: Administration, Oral; Adult; Anticonvulsants; Area Under Curve; Body Mass Index; Carbamazepine; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Enzyme Induction; Ethinyl Estradiol; Female; Fructose; Humans; Mestranol; Metabolic Clearance Rate; Norethindrone; Obesity; Topiramate | 2003 |
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Progesterone Congeners | 2003 |
Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Appetite Depressants; Blood Pressure; Body Constitution; Body Weight; Cyclobutanes; Cyproterone Acetate; Diastole; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Obesity; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2003 |
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Topics: Abdomen; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hypoglycemic Agents; Metformin; Norpregnenes; Obesity; Polycystic Ovary Syndrome | 2004 |
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cardiovascular Diseases; Cholesterol; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Treatment Outcome | 2005 |
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.
Topics: Adolescent; Adult; Androgens; Blood Glucose; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
The effect of ethinyl estradiol-cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Homocysteine; Humans; Lipids; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Testosterone | 2008 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metformin; Obesity; Polycystic Ovary Syndrome; Risk Factors; Uric Acid | 2008 |
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Diet, Reducing; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Lipolysis; Norethindrone; Obesity; Polycystic Ovary Syndrome; Radioligand Assay; Sympathetic Nervous System; Weight Loss | 1999 |
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Topics: Adult; Androgen Antagonists; Area Under Curve; Blood Glucose; Calorimetry; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Fats; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome | 2000 |
Oral contraceptive medication and glucose metabolism: long-term treatment.
Topics: Adult; Blood Glucose; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Diabetes Mellitus; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Middle Aged; Norethindrone; Obesity; Pregnancy; Triglycerides | 1974 |
Liver reaction in connection with oral contraceptive steroids.
Topics: Adolescent; Adult; Alkaline Phosphatase; Amenorrhea; Bilirubin; Carbohydrate Metabolism; Clinical Trials as Topic; Contraceptives, Oral; Ethinyl Estradiol; Female; Hemorrhage; Humans; Jaundice; L-Lactate Dehydrogenase; Lipid Metabolism; Liver; Lynestrenol; Mestranol; Middle Aged; Nausea; Norethynodrel; Obesity; Ornithine Carbamoyltransferase; Proteins; Pruritus; Thrombophlebitis | 1969 |
31 other study(ies) available for ethinyl estradiol and Obesity
Article | Year |
---|---|
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin | 2021 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Oral hormonal therapy with ethinylestradiol-levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating mineralocorticoid in estrogen-deficient rats.
Topics: Administration, Oral; Animals; Body Weight; Drug Combinations; Eating; Estradiol; Estrogens; Ethinyl Estradiol; Fasting; Female; Glycogen Synthase Kinase 3; Insulin Resistance; Insulin-Secreting Cells; Intra-Abdominal Fat; Levonorgestrel; Mineralocorticoids; Obesity; Rats; Rats, Wistar; Triglycerides | 2018 |
Blood pressure predicts endothelial function and the effects of ethinyl estradiol exposure in young women.
Topics: Adiposity; Administration, Oral; Adolescent; Adult; Antihypertensive Agents; Arterial Pressure; Brachial Artery; Drug Administration Schedule; Endothelium, Vascular; Ethinyl Estradiol; Exercise Test; Female; Hand Strength; Humans; Hypertension; Ischemia; Obesity; Time Factors; Treatment Outcome; Vasodilator Agents; Young Adult | 2018 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol/drosperinone combined contraceptive pills: a 3-year case-control study.
Topics: Adult; Androstenes; Case-Control Studies; Ethinyl Estradiol; Female; Humans; Obesity; Overweight; Prospective Studies; Reproductive Control Agents | 2016 |
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Levonorgestrel; Luteinizing Hormone; Obesity; Young Adult | 2009 |
Short-term ethinyl estradiol treatment suppresses inferior caval vein thrombosis in obese mice.
Topics: Adipose Tissue; Animals; Blood Coagulation Factors; Dietary Fats; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Inflammation; Interleukin-6; Lipids; Liver; Mice; Mice, Inbred C57BL; Models, Biological; Obesity; Organ Size; Ovariectomy; Serum Amyloid A Protein; Species Specificity; Thrombophilia; Uterus; Vena Cava, Inferior; Venous Thrombosis | 2009 |
Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.
Topics: Adult; C-Reactive Protein; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Follistatin; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies | 2010 |
Antimullerian hormone and obesity: insights in oral contraceptive users.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Body Mass Index; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Levonorgestrel; Luteinizing Hormone; Obesity; Regression Analysis | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Combined oral contraceptives and body weight: do oral contraceptives cause weight gain? A primate model.
Topics: Animals; Basal Metabolism; Body Composition; Body Weight; Contraceptives, Oral, Combined; Energy Intake; Ethinyl Estradiol; Female; Levonorgestrel; Macaca mulatta; Obesity | 2011 |
Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Obesity; Progesterone; Prospective Studies | 2013 |
[Choosing contraception for adolescents].
Topics: Adolescent; Age Factors; Behavior; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Demography; Disease; Estrogens; Ethinyl Estradiol; Europe; Family Planning Services; France; Hormones; Intrauterine Devices; Obesity; Population; Population Characteristics; Sexual Behavior; Spermatocidal Agents | 1985 |
Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral; Diet, Vegetarian; Ethinyl Estradiol; Female; Folic Acid; Humans; Obesity; Smoking; Vitamin B 12; Vitamin B 12 Deficiency | 2003 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
THE HORMONES AND PUBERTY.
Topics: Adolescent; Child; Chorionic Gonadotropin; Cryptorchidism; Diethylstilbestrol; Ethinyl Estradiol; Eunuchism; Female; Genital Neoplasms, Female; Gonadotropins; Humans; Hypogonadism; Hypothalamus; Klinefelter Syndrome; Male; Menstruation; Methyltestosterone; Obesity; Physiology; Puberty; Puberty, Precocious; Sexual Maturation; Surgical Procedures, Operative; Testosterone; Thyroid Gland; Thyroxine | 1964 |
Clinical inquiries. What hormonal contraception is most effective for obese women?
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment | 2007 |
Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP.
Topics: Adolescent; Anemia, Iron-Deficiency; Anticoagulants; Brain Edema; Combined Modality Therapy; Dexamethasone; Ethinyl Estradiol; Fatal Outcome; Female; Heparin; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Jugular Veins; Mannitol; Metrorrhagia; Norethindrone; Obesity; Purpura, Thrombocytopenic, Idiopathic; Thrombectomy; Thrombolytic Therapy; Venous Thrombosis | 2008 |
Thermogenic drugs for the treatment of obesity: screening using obese rats and mice.
Topics: Animals; Body Weight; Eating; Ephedrine; Ethinyl Estradiol; Male; Mice; Mice, Inbred CBA; Obesity; Oxygen Consumption; Rats; Triiodothyronine | 1983 |
[The influence of oral contraceptives on lipoprotein status (author's transl)].
Topics: Adolescent; Adult; Blood Donors; Contraceptives, Oral; Cyproterone; Estrogens; Ethinyl Estradiol; Female; Humans; Lipoproteins; Lipoproteins, LDL; Mestranol; Obesity; Progesterone Congeners; Smoking | 1982 |
[The desogestrel-ethinyl estradiol combination and overweight: current data].
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Obesity; Progesterone Congeners; Time Factors | 1995 |
[Hormonal regulation and hormone therapy in childhood and adolescence. Part 2: Therapeutic problems (tall stature, amenorrhea, delayed puberty, oligomenorrhea, precocious puberty, anorexia nervosa, anisomastia, hypermastia, acne etc)].
Topics: Acne Vulgaris; Adolescent; Amenorrhea; Anorexia Nervosa; Breast Diseases; Child; Cyproterone; Drug Combinations; Endocrine System Diseases; Estradiol Congeners; Ethinyl Estradiol; Female; Growth Disorders; Hirsutism; Humans; Menstruation Disturbances; Obesity; Oligomenorrhea; Progesterone Congeners; Puberty, Precocious | 1979 |
[Hypophyseal hormonal rhythm in a physiological state].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Cushing Syndrome; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Melanocyte-Stimulating Hormones; Middle Aged; Norgestrel; Obesity; Pituitary Hormones, Anterior; Pregnancy; Prolactin; Thyrotropin | 1975 |
[Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].
Topics: Adult; Age Factors; Blood Glucose; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diabetes Mellitus; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lynestrenol; Mathematics; Megestrol; Mestranol; Middle Aged; Norethindrone; Norgestrel; Obesity; Time Factors | 1976 |
Acute coronary artery disease and oral contraceptives.
Topics: Acute Disease; Adult; Contraceptives, Oral; Coronary Disease; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Myocardial Infarction; Obesity; Pregnancy; Pregnancy Complications, Cardiovascular; Smoking | 1975 |
[Disorders of carbohydrate metabolism induced by steroid contraceptive agents].
Topics: Carbohydrate Metabolism; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Diabetes Mellitus; Ethinyl Estradiol; Female; Growth Hormone; Humans; Insulin; Insulin Secretion; Mestranol; Obesity; Progestins; Secretory Rate; Time Factors; Tryptophan; Vitamin B 6 Deficiency | 1975 |
Malignant hypertension associated with use of oral contraceptives.
Topics: Adult; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypertension, Malignant; Norethindrone; Obesity | 1975 |
Serum-lipids in women on oral contraceptives.
Topics: Age Factors; Body Weight; Cholesterol; Contraceptives, Oral; Coronary Disease; Estrogens; Ethinyl Estradiol; Fasting; Female; Humans; Hyperlipidemias; Lipids; Mestranol; Obesity; Parity; Progestins; Pulmonary Embolism; Thrombophlebitis; Time Factors; Triglycerides | 1971 |
The use of oestrogen-progestogen preparations in the treatment of hirsutism in the female.
Topics: 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Amenorrhea; Dexamethasone; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Hirsutism; Humans; Mestranol; Obesity; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone | 1974 |
The effects of oral contraceptives on glucose tolerance.
Topics: Administration, Oral; Adult; Blood Glucose; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Menopause; Mestranol; Middle Aged; Norgestrel; Obesity; Ovulation; Time Factors | 1968 |